motor behaviors. The first was the forward optomotor response (OMR) 1, 2 , in which swimming is elicited by visual gratings moving in the tail-to-head direction. In our system, the OMR during light-sheet scanning was comparable to the OMR without the presence of the light sheets (Fig. 1c) . We defined an optomotor index as the difference in swimming strength during and before stimulus presentation. This index was significantly positive in all fish tested, with or without the laser (P = 0.031 with laser and P = 0.031 without it; two-sided sign test, n = 6 fish), and its magnitude was comparable between the two conditions (optomotor index: 0.67 ± 0.13 with the laser and 0.72 ± 0.067 without it, mean ± s.d.; P = 0.22, two-sided paired sign test).
We also tested a more complex behavior: fictive motor adaptation, where the fish adapts its motor output to the strength of visual feedback in a closed-loop paradigm 1 . Again, the behavior was comparable with and without the light sheets (Fig. 1d) . We defined a gain adaptation index as the ratio of swimming during low gain and high gain. This index was significantly greater than 1 in all fish tested (P = 0.0078 with laser and P = 0.0078 without it; two-sided sign test, n = 8). Its magnitude was also comparable between the two conditions (gain adaptation index: 2.08 ± 0.57 with the laser and 1.91 ± 0.47 without it, mean ± s.d.; P = 0.29, two-sided paired sign test).
The preservation of the OMR and gain adaptation indicates that whole-brain light-sheet imaging is compatible with fictive virtualreality assays and can be used to interrogate whole-brain activity during visuomotor behavior. As an example, we measured wholebrain activity during the OMR in a 6 d.p.f. transgenic zebrafish expressing the genetically encoded calcium indicator GCaMP6s 8 under the pan-neuronal elavl3 promoter (Supplementary Note). Light-sheet imaging captures stimulus and motor-dependent patterns of whole-brain neural activity ( Fig. 1e and Supplementary Video 1) with single-cell resolution across most of the brain (Fig. 1f,g and Supplementary Note). Cells and neuropil distributed across the brain showed activity during the optomotor response. We additionally assessed resolution using a fish with nuclear-localized (histone H2B fusion) expression of GCaMP6s (Supplementary Note, Supplementary Figs. 2 and 3, and Supplementary Video 2). Fish lines and DNA constructs for elavl3:GCaMP6s and elavl3:H2B-GCaMP6s are available upon request.
We presented a system for monitoring neural activity, at the cellular level, across the entire brain of the larval zebrafish during visuomotor behavior. Resources associated with this work, including sample data and analysis resources, are available via http://research. janelia.org/zebrafish/. This system, in combination with large-scale data analysis methods described in a companion paper 9 , holds promise for advancing the understanding of how activity in large networks of neurons underlies behavior. 
Guided visual exploration of genomic stratifications in cancer
To the Editor: Cancer is a heterogeneous disease, and molecular profiling of tumors from large cohorts has enabled characterization of new tumor subtypes. This is a prerequisite for improving personalized treatment and ultimately achieving better patient outcomes. Potential tumor subtypes can be identified with methods such as unsupervised clustering 1 or network-based stratification 2 , which assign patients to sets based on high-dimensional molecular profiles. Detailed characterization of identified sets and their interpretation, however, remain a time-consuming exploratory process.
To address these challenges, we combined 'StratomeX' 3 , an interactive visualization tool that is freely available at http://www.caleydo.org/, with exploration tools to efficiently compare multiple patient stratifications, to correlate patient sets with clinical information or genomic alterations and to view the differences between molecular profiles across patient sets. Although we focus on cancer genomics here, StratomeX can also be applied in other disease cohorts.
Thousands of patient stratifications can be derived from large cancer genomics datasets. This space of patient stratifications-which we call the 'stratome'-contains stratifications based on, for example, clustering of mRNA, microRNA or protein expression matrices; the mutation or copy number status of genes; or on clinical variables. Owing to the size of the stratome and the heterogeneity of the underlying datasets, integration of computational and visual approaches is indispensable to the analyst in identifying biologically or clinically meaningful stratifications as well as clinical parameters and pathways that together provide a comprehensive view of each patient set.
StratomeX complements the network viewers, heat maps and genome browsers typically used in cancer genomics 4 Table 1) . To visualize the relationships between multiple patient stratifications as well as other data ( Fig. 1 and Supplementary Fig. 1 ), stratifications are represented as columns of stacked blocks where each block corresponds to a patient set. Blocks contain visualizations of the data associated with those patients, such as heat maps, pathway maps overlaid with expression data or survival plots ( Supplementary  Fig. 2) . Bands connecting the blocks show the pairwise overlap of sets in adjacent stratifications, with the width of the bands representing the size of the overlap relative to the size of the patient sets (Supplementary Fig. 3 ). This visualization is an efficient tool to confirm hypotheses about gene functions or subtypes defined by molecular profiles.
StratomeX also integrates a computational framework for querybased guided exploration of the stratome directly into the visualization (Fig. 1) , which enables discovery of novel relationships between patient sets and efficient generation and refinement of hypotheses about tumor subtypes. A 'query wizard' provides stepby-step instructions (Supplementary Figs. 1 and 4 Methods) . The queries yield a score for each stratification, for example, based on their overlap with a particular patient set or based on their overall similarity to a selected stratification. Furthermore, the analyst can query the collection for stratifications that contain patient sets that exhibit differences in survival or differential regulation of pathways. We use 'LineUp' 5 , a multi-attribute ranking technique, to visualize the results of these queries and to show which stratifications or pathways score highly ( Fig. 1 and Supplementary Fig. 5 ). The tight integration between the StratomeX and LineUp views, as well as the dynamic computation of scores, is essential for rapid identification of meaningful relationships between stratifications, clinical parameters and pathways. We demonstrate the effectiveness of StratomeX in a case study (Supplementary Note, Supplementary Figs. 6-18, Supplementary  Tables 2 and 3, Supplementary Data 1-4 and Supplementary Video 1) in which we explored molecular and clinical data to characterize tumor subtypes in a cohort of over 400 clear cell renal cell carcinoma cases reported by The Cancer Genome Atlas consortium 6 . 
